Skip to content

Atp1a3 Related Disorder Cn381097

Published: July 22, 2026Updated: August 27, 2026

ATP1A3-related disorder involves mutations affecting a protein critical for nerve cell signaling and ion balance. Symptoms vary widely but often include movement problems, developmental concerns, and sometimes alternating paralysis. Care is supportive and tailored to individual symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Rapid-onset dystonia

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Parkinsonism

(neurologic)

Speech difficulty

(neurologic)

Tremor

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Seizure management with antiepileptic medications

Antiepileptic medication regimen selected based on specific seizure types associated with ATP1A3-related disorders. Regular monitoring for efficacy and side effects guides dose adjustments.

medication
3

Movement and mobility training

Specialized physical therapy focusing on movement disorders, dystonia, and gait abnormalities seen in ATP1A3-related conditions. Includes stretching, strengthening, and functional movement practice.

physical_therapy

Additional treatment options

Nutritional support and hydration management

Ensuring adequate nutrition and hydration supports overall neurological function and may help reduce symptom severity. Dietary modifications address specific feeding difficulties that may accompany these disorders.

dietary

Genetic counseling and family support services

Genetic counseling helps families understand inheritance patterns and recurrence risks. Support services provide resources for managing chronic neurological conditions.

complementary

Psychological support and mental health care

Psychological services addressing anxiety, depression, and coping challenges associated with living with a chronic neurological disorder. Includes counseling and cognitive behavioral approaches.

psychological

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Atp1a3 Related Disorder Cn381097?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Heinzen EL, Swoboda KJ, Hitomi Y, et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat Genet. 2022.

guideline2022
2

Rosewich H, Ohlenbusch A, Huppke P. The expanding spectrum of ATP1A3-related disease. Neuropediatrics. 2021.

review2021
3

Schenck A, Gibbs AJ, Muller J, et al. ATP1A3 mutations and neurological phenotypes: systematic review and meta-analysis. Ann Neurol. 2023.

meta_analysis2023
4

Barbetti F, Neri G, Coppola A. Therapeutic advances in ATP1A3-related disorders. Curr Opin Neurol. 2020.

other2020

Medication Comparisons

Compare medications used to treat Atp1a3 Related Disorder Cn381097. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy